gene profiling (ExonHit Therapeutics SA)
90
Structured Review
ExonHit Therapeutics SA
gene profiling
Gene Profiling, supplied by ExonHit Therapeutics SA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/microarray+expression+profile+datasets/expression+profiling+microarrays/pmc03367799-118-5-0
Average 90 stars, based on 1 article reviews
Gene Profiling, supplied by ExonHit Therapeutics SA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/microarray+expression+profile+datasets/expression+profiling+microarrays/pmc03367799-118-5-0
Average 90 stars, based on 1 article reviews
gene profiling - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
other:Article Title: Abstracts of the 30th Annual San Antonio Breast Cancer Symposium. December 13-16, 2007. San Antonio, Texas, USA. Article Snippet: General Sessions [#11-82] S5–S23 Poster Discussion Sessions [#101-511] S24–S40 Poster Session I [#1001-1119] S41–S83 Poster Session II [#2001-2121] S84–S125 Poster Session III [#3001-3113] S126–S165 Poster Session IV [#4001-4117] S166–S206 Poster Session V [#5001-5119 (excl.. 5015)] S207–S246 Poster Session VI [#6001-6119 plus 5015] S247–S287 Author index for abstracts S288–S302 Article Title: A new map for human genome expression Article Snippet: The drug and diagnostic discovery company, ExonHit Therapeutics (MD, USA), has recently announced the completion of a new mRNA transcript map derived from human genome expression.. Success was obtained following many years of research, including, in particular, the discovery of alternative splicing events that serve as key components of transcriptome diversity.. ExonHit’s new human genome map will allow researchers to characterize transcripts expressed from genes of their choice rapidly and efficiently. Article Title: The pre-clinical discovery of Amyotrophic Lateral Sclerosis Drugs Article Snippet: Biomarker Discovery:Article Title: Alternative isoform discrimination by the next generation of expression profiling microarrays. Article Snippet: Alternative isoform discrimination by the next generation of expression profiling microarrays Matthew P Pando, Vinayaka Kotraiah, Kevin McGowan, Laurent Bracco & Richard Einstein a ExonHit Therapeutics, Inc., 217 Perry Parkway, Bdg 5, Gaithersburg, MD 20877, USA. b UNC-Chapel Hill, Suite 3100 Thurston Bowles Bldg, CB #7287, Chapel Hill, NC 27599-7287, USA c ExonHit Therapeutics, SA, 65, Bld Massena, F-75013 Paris, France Published online: 16 May 2015. Expressing:Article Title: Alternative isoform discrimination by the next generation of expression profiling microarrays. Article Snippet: Alternative isoform discrimination by the next generation of expression profiling microarrays Matthew P Pando, Vinayaka Kotraiah, Kevin McGowan, Laurent Bracco & Richard Einstein a ExonHit Therapeutics, Inc., 217 Perry Parkway, Bdg 5, Gaithersburg, MD 20877, USA. b UNC-Chapel Hill, Suite 3100 Thurston Bowles Bldg, CB #7287, Chapel Hill, NC 27599-7287, USA c ExonHit Therapeutics, SA, 65, Bld Massena, F-75013 Paris, France Published online: 16 May 2015. |
